SiNtx Technologies Inc (SINT)

[boston745]

Speaking of accumulated deficit. That alone represents significant value for an acquiring company, specifically Zimmer Biomet which would have the best idea of Sintx business, material, etc.. As Sintx has no debt, only assets (offset by small amount of operating liabilities) and this large deficit, an acquiring company would get this large $270m tax offset assuming Sintx can profit as much as its deficit. I of course believe Sintx can for any acquiring company but particular its strategic partners like Zimmer Biomet because its addressable markets are worth upper tens of billions to over $100 billion.

No matter which way you look at it, Sintx is so undervalued that it represents significant value for value investors. Caution is of course needed because of the short and distort campaign being waged against it. One need only look at how posters on this forum, outside myself, focus and overly emphasize the negative aspects of the company. They overplay the negative and downplay all the positives if not ignore them altogether, in their posts. All of which is examples of distorting and bashing oriented posting.

1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments.

https://fastercapital.com/content/Market-Hype--Unmasking-Stock-Bashers--Attempts-to-Manipulate-Buzz.html

========================================

This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546

This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544

I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472

========================================

The Value being created at Sintx can be seen in the following posts and links:

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883

========================================

Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281

========================================

Silicon Nitride = Next Gen Hip Implant Material

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies

Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/

Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779